sarpogrelate has been researched along with Elevated Cholesterol in 2 studies
sarpogrelate: structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, T | 1 |
| Sumi, D | 1 |
| Matsui-Hirai, H | 1 |
| Fukatsu, A | 1 |
| Arockia Rani P, J | 1 |
| Kano, H | 1 |
| Tsunekawa, T | 1 |
| Iguchi, A | 1 |
| Origuchi, N | 1 |
| Shigematsu, H | 1 |
| Muto, T | 1 |
2 other studies available for sarpogrelate and Elevated Cholesterol
| Article | Year |
|---|---|
Sarpogrelate HCl, a selective 5-HT2A antagonist, retards the progression of atherosclerosis through a novel mechanism.
Topics: Acetylcholine; Animals; Antioxidants; Aorta, Thoracic; Biomarkers; Blood Proteins; Cholesterol, HDL; | 2003 |
Anplag, a selective 5-HT2 receptor antagonist, reduces stenosis induced by balloon injury in the hypercholesterolaemic rabbit.
Topics: Administration, Oral; Angioplasty, Balloon; Animals; Carotid Artery Injuries; Carotid Artery, Common | 1997 |